IndiaTickerCertificate under SEBI (Depositories and Participants) Regulations, 2018 - Bafna Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing Company dossier
Bafna Pharmaceuticals
NSE:BAFNAPH · ISIN INE878I01022
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Bafna Pharmaceuticals
Filings
Preserved evidence
40 recent eventsPrimary-source filing timeline
Bafna Pharmaceuticals Ltd - 532989 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Disclosure under SEBI Takeover Regulations - Bafna Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing Trading Window - Bafna Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing Bafna Pharmaceuticals Ltd - 532989 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Retirement - Bafna Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing Bafna Pharmaceuticals Ltd - 532989 - Announcement under Regulation 30 (LODR)-Change in DirectorateBSE · exchange filing · pdf
Source filing Bafna Pharmaceuticals Ltd - 532989 - Announcement under Regulation 30 (LODR)-RetirementBSE · exchange filing · pdf
Source filing Bafna Pharmaceuticals Ltd - 532989 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · financial results · pdf
Source filing Copy of Newspaper Publication - Bafna Pharmaceuticals LimitedNSE · financial results · pdf
Source filing Bafna Pharmaceuticals Ltd - 532989 - Board Meeting Outcome for Outcome Of The Board Meeting Held On May 29, 2026BSE · financial results · pdf
Source filing Bafna Pharmaceuticals Ltd - 532989 - Audited Financial Results For Quarter And Year Ended March 31, 2026BSE · financial results · pdf
Source filing Outcome of Board Meeting - Bafna Pharmaceuticals LimitedNSE · financial results · pdf
Source filing Disclosure under SEBI Takeover Regulations - Bafna Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing Bafna Pharmaceuticals Ltd - 532989 - Board Meeting Intimation for Meeting Scheduled On May 29, 2026BSE · exchange filing · pdf
Source filing Bafna Pharmaceuticals Ltd - 532989 - Clarification On Price MovementBSE · exchange filing · pdf
Source filing Price movement - Bafna Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing Bafna Pharmaceuticals Ltd - 532989 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Certificate under SEBI (Depositories and Participants) Regulations, 2018 - Bafna Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing Bafna Pharmaceuticals Ltd - 532989 - Board Meeting Outcome for Outcome For Board Meeting Held On 27/03/2026BSE · exchange filing · pdf
Source filing Outcome of Board Meeting - Bafna Pharmaceuticals LimitedNSE · financial results · pdf
Source filing Bafna Pharmaceuticals Ltd - 532989 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Trading Window - Bafna Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing Bafna Pharmaceuticals Ltd - 532989 - Clarification On Price MovementBSE · exchange filing · pdf
Source filing Price movement - Bafna Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing Bafna Pharmaceuticals Ltd - 532989 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · financial results · pdf
Source filing Copy of Newspaper Publication - Bafna Pharmaceuticals LimitedNSE · financial results · pdf
Source filing Bafna Pharmaceuticals Ltd - 532989 - Unaudited Financial Results For The Quarter And Nine Months Ended On December 31, 2025BSE · financial results · pdf
Source filing Bafna Pharmaceuticals Ltd - 532989 - Board Meeting Outcome for Outcome For The Board Meeting Held On 11/02/2026BSE · financial results · pdf
Source filing Outcome of Board Meeting - Bafna Pharmaceuticals LimitedNSE · financial results · pdf
Source filing Bafna Pharmaceuticals Ltd - 532989 - Board Meeting Intimation for Meeting Scheduled On February 11, 2026BSE · exchange filing · pdf
Source filing Bafna Pharmaceuticals Ltd - 532989 - Announcement under Regulation 30 (LODR)-Credit RatingBSE · credit rating · pdf
Source filing Credit Rating- Revision - Bafna Pharmaceuticals LimitedNSE · credit rating · pdf
Source filing Bafna Pharmaceuticals Ltd - 532989 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Certificate under SEBI (Depositories and Participants) Regulations, 2018 - Bafna Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing Bafna Pharmaceuticals Ltd - 532989 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing Trading Window - Bafna Pharmaceuticals LimitedNSE · exchange filing · pdf
Source filing Bafna Pharmaceuticals Ltd - 532989 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · financial results · pdf
Source filing Copy of Newspaper Publication - Bafna Pharmaceuticals LimitedNSE · financial results · pdf
Source filing Bafna Pharmaceuticals Ltd - 532989 - Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2025BSE · financial results · pdf
Source filing